Literature DB >> 28169127

Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.

Kun Li1, Huaie Liu2, Tao Guo3.   

Abstract

OBJECTIVE: To determine the impact of T helper 17 cell (Th17)/regulatory T cell (Treg) ratio imbalance on the process and prognosis of hepatitis B virus (HBV)-related liver cirrhosis.
METHODS: Patients with HBV who refused to accept any therapy from were recruited from 2009 to 2014 and followed-up to August 2016. Based on a liver stiffness measurement (LSM), the patients were divided into a low LSM group and a high LSM group. After propensity score matching, 150 patients were included. The peripheral blood of all subjects was tested using a flow cytometer to measure the Th17 and Treg cell frequencies and the Th17/Treg ratio. Spearman rank correlation, log-rank test, Cox regression model, and receiver operating characteristic (ROC) curves were applied to analyze the correlation between the Th17/Treg ratio and LSM level and the risk factors of HCC occurrence and to predict the Th17/Treg ratio for the LSM level.
RESULTS: Th17 and Treg cell frequencies and the Th17/Treg ratio were significantly different between the low and high LSM groups. The Th17/Treg ratio showed a strong positive association with LSM level (r=0.631, P<0.01). Furthermore, the Th17/Treg ratio was an independent factor influencing the HCC occurrence, which was tested using a Cox regression model. The area under the ROC curve of the Th17/Treg ratio for predicting LSM level was 0.783 (95% CI 0.705-0.861).
CONCLUSION: Th17/Treg ratio imbalance is an indicator of the liver cirrhosis process and a risk factor for HCC occurrence in patients infected with HBV.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28169127     DOI: 10.1016/j.clinre.2016.12.004

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  9 in total

1.  Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg/Th17 immune homeostasis.

Authors:  Weiwei Ji; Xin Peng; Tianling Lou; Juan Wang; Wenyu Qiu
Journal:  Inflammopharmacology       Date:  2019-05-23       Impact factor: 4.473

2.  The day will come to treat HCC in a drugstore?

Authors:  Kouichi Miura
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

3.  [Effects of hepatitis B virus on Th17, Treg and Th17/Treg ratio in different alanine aminetransferase stages].

Authors:  P Gao; Y P Luo; J F Li; I Chen; X R Mao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-18

Review 4.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

Review 5.  Dairy consumption and hepatocellular carcinoma risk.

Authors:  Bodo C Melnik
Journal:  Ann Transl Med       Date:  2021-04

6.  Detection of Treg/Th17 cells and related cytokines in peripheral blood of chronic hepatitis B patients combined with thrombocytopenia and the clinical significance.

Authors:  Yinghui Wang; Liru Wang; Wei Gao; Xi Chen; Yanhua Su
Journal:  Exp Ther Med       Date:  2018-06-14       Impact factor: 2.447

Review 7.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

8.  Interleukin 10 Gene-Modified Bone Marrow-Derived Dendritic Cells Attenuate Liver Fibrosis in Mice by Inducing Regulatory T Cells and Inhibiting the TGF-β/Smad Signaling Pathway.

Authors:  Yejin Xu; Xinyue Tang; Min Yang; Shengguo Zhang; Shanshan Li; Yukai Chen; Minhui Liu; Yuxiang Guo; Mingqin Lu
Journal:  Mediators Inflamm       Date:  2019-01-17       Impact factor: 4.711

Review 9.  Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.

Authors:  Bridget P Keenan; Lawrence Fong; Robin K Kelley
Journal:  J Immunother Cancer       Date:  2019-10-18       Impact factor: 13.751

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.